Ramsay Health Care Has Clear Pathway for New Asset -- Market Talk

Dow Jones

Mar 26

2257 GMT [Dow Jones]--Ramsay Health Care's bull at Macquarie sees an immediate pathway for it to improve performance at its newly acquired Canberra hospital. A note from one of the investment bank's analysts flags that the National Capital Private Hospital has been operating below its potential. The analyst outlines a belief that Ramsay's operating framework should provide a way to immediately lift throughput and efficiency without material incremental capital expenditure. The analyst sees the asset delivering a steady build in revenue and earnings as volumes and workflows improve, supported by procurement and labor benefits. Macquarie lowers its target price 3.8% to A$43.40 and keeps an outperform rating on the stock, which is at A$40.21 ahead of the open. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

March 25, 2026 19:00 ET (23:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2622888038"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622888038\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622888038?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 07:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622888038","market":"sh","top_or_hot":-1,"title":"Ramsay Health Care Has Clear Pathway for New Asset -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  2257 GMT [Dow Jones]--<a href=\"https://laohu8.com/S/RMSYF\">Ramsay Health Care</a>'s bull at <a href=\"https://laohu8.com/S/MQG.AU\">Macquarie</a> sees an immediate pathway for it to improve performance at its newly acquired Canberra hospital. A note from one of the investment bank's analysts flags that the National Capital Private Hospital has been operating below its potential. The analyst outlines a belief that Ramsay's operating framework should provide a way to immediately lift throughput and efficiency without material incremental capital expenditure. The analyst sees the asset delivering a steady build in revenue and earnings as volumes and workflows improve, supported by procurement and labor benefits. Macquarie lowers its target price 3.8% to A$43.40 and keeps an outperform rating on the stock, which is at A$40.21 ahead of the open. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2026 19:00 ET (23:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ramsay Health Care Has Clear Pathway for New Asset -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRamsay Health Care Has Clear Pathway for New Asset -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-26 07:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  2257 GMT [Dow Jones]--<a href=\"https://laohu8.com/S/RMSYF\">Ramsay Health Care</a>'s bull at <a href=\"https://laohu8.com/S/MQG.AU\">Macquarie</a> sees an immediate pathway for it to improve performance at its newly acquired Canberra hospital. A note from one of the investment bank's analysts flags that the National Capital Private Hospital has been operating below its potential. The analyst outlines a belief that Ramsay's operating framework should provide a way to immediately lift throughput and efficiency without material incremental capital expenditure. The analyst sees the asset delivering a steady build in revenue and earnings as volumes and workflows improve, supported by procurement and labor benefits. Macquarie lowers its target price 3.8% to A$43.40 and keeps an outperform rating on the stock, which is at A$40.21 ahead of the open. (stuart.condie@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2026 19:00 ET (23:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBI","symbol_name":"SPDR S&P Biotech ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2622888038","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622888038","pubTimestamp":1774479600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2257 GMT [Dow Jones]--Ramsay Health Care's bull at Macquarie sees an immediate pathway for it to improve performance at its newly acquired Canberra hospital. A note from one of the investment bank's analysts flags that the National Capital Private Hospital has been operating below its potential. The analyst outlines a belief that Ramsay's operating framework should provide a way to immediately lift throughput and efficiency without material incremental capital expenditure. The analyst sees the asset delivering a steady build in revenue and earnings as volumes and workflows improve, supported by procurement and labor benefits. Macquarie lowers its target price 3.8% to A$43.40 and keeps an outperform rating on the stock, which is at A$40.21 ahead of the open. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","RHC.AU":"RAMSAY HEALTH CARE LTD","LABU":"三倍做多标普生物-Direxion","BK7113":"保健护理机构","BK4585":"ETF&股票定投概念","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR"},"translate_title":"拉姆齐医疗保健公司拥有明确的新资产途径——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"RHC.AU":0.9,"LABU":0.6,"XBI":0.6},"content_text":"2257 GMT [Dow Jones]--Ramsay Health Care's bull at Macquarie sees an immediate pathway for it to improve performance at its newly acquired Canberra hospital. A note from one of the investment bank's analysts flags that the National Capital Private Hospital has been operating below its potential. The analyst outlines a belief that Ramsay's operating framework should provide a way to immediately lift throughput and efficiency without material incremental capital expenditure. The analyst sees the asset delivering a steady build in revenue and earnings as volumes and workflows improve, supported by procurement and labor benefits. Macquarie lowers its target price 3.8% to A$43.40 and keeps an outperform rating on the stock, which is at A$40.21 ahead of the open. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 19:00 ET (23:00 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}